10X Genomics, Inc. (NASDAQ:TXG) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET
Company Participants
Cassie Corneau - Manager, IR and Strategic Finance
Serge Saxonov - Co-Founder, CEO & Director
Justin McAnear - CFO
Conference Call Participants
Patrick Donnelly - Citigroup
Daniel Arias - Stifel, Nicolaus & Company
Kyle Boucher - TD Cowen
Michael Ryskin - Bank of America Merrill Lynch
Tejas Savant - Morgan Stanley
Matthew Larew - William Blair & Company
Mason Carrico - Stephens Inc.
Tianqi Hang - UBS
Kyle Mikson - Canaccord Genuity
Justin Bowers - Deutsche Bank
Noah Burhance - JPMorgan Chase & Co.
Operator
Hello, everyone. Welcome to the 10x Genomics Second Quarter 2023 Earnings Conference Call. I will now hand the call over to your host, Cassie Corneau. Cassie, please go ahead.
Cassie Corneau
Thank you and good afternoon, everyone. Earlier today, 10x Genomics released financial results for the second quarter ended June 30, 2023. If you have not received this news release, or if you would like to be added to the company's distribution list, please send an email to investors@10xgenomics.com. An archived webcast of this call will be available on the investor tab of the company’s website, 10xgenomics.com, for at least 45 days following this call.
Before we begin, I'd like to remind you that management will make statements during this call that are forward looking statements within the meaning of Federal Securities Laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties and factors that could cause results to differ appears in the press release 10x Genomics issued today and in the documents and reports filed by 10x Genomics from time to time with the Securities and Exchange Commission. 10x Genomics disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.
Joining the call today are Serge Saxonov, our CEO and Co-Founder and Justin McAnear, our Chief Financial Officer.
We will host a question-and-answer session after our prepared remarks. [Operator Instructions].
With that, I will now turn the call over to Serge.
Serge Saxonov
Thanks, Cassie, and good afternoon, everyone. On today's call, I will start with an overview of our strong second quarter performance in both single cell and spatial. Next, I will share an update on our progress and momentum in each of our three platforms, highlighted by our customers’' tremendous enthusiasm for and rapid adoption of Xenium. I will then turn the call over to Justin for a more detailed look at our financials, business trends and outlook for the rest of the year.